NCT00163150View on ClinicalTrials.gov

Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

February 28, 2006

Conditions
Cerebrovascular AccidentHypercholesterolemia
Interventions
DRUG

Atorvastatin

Trial Locations (1)

75877

Pfizer Investigational Site, Paris

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00163150 - Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke | Biotech Hunter | Biotech Hunter